Study to Better Understand Chemotherapy in Older Patients

What we are studying

The purpose of this study is to identify questions and blood tests that can be used to better understand which older patients will be able to tolerate chemotherapy and why. A majority of patients diagnosed with cancer are over age 65, yet most cancer treatments are developed for a younger population. As a consequence, older patients with cancer are less likely to be offered standard treatments because of the concern regarding side effects. There are no standard tools in oncology practice that can identify which older adults will be more likely to have side effects from chemotherapy. The goal of this study is to develop questions and blood tests to understand the individual’s risk of side effects that can be utilized in daily oncology practice. This information will make it possible to weigh the risks and benefits of cancer treatment based on factors other than chronological age.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 65+

Eligibility Criteria

  • Must have stage I-III Breast Cancer and receiving Chemotherapy

What is involved

  • You will be in the study for as long as you receive chemotherapy or a maximum of 1 month later to complete the questionnaires and blood tests again.



Contact Information

Study Coordinator
Stacey Lewis
[email protected]



Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.